| Alvocidib studied in …STUDIED_INderived63 of 63show fewer |
|---|
| → studied in | NCT02520011Phase 2 · terminated Alvocidib Biomarker-driven Phase 2 AML Study · 63 trials list this drug (0 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03298984Phase 1 · completed Ph I Study of Alvocidib and Cytarabine/Daunorubicin (7+3) in Patients With Newly Diagnosed Acute Myeloid Leukemia (AML). · 63 trials list this drug (0 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03969420Phase 2 · terminated Study of Alvocidib in Patients With Relapsed/Refractory AML Following Treatment With Venetoclax Combination Therapy · 63 trials list this drug (0 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03563560Phase 1 · completed A Study of DSP-2033 (Alvocidib) in Patients With Acute Myeloid Leukemia · 63 trials list this drug (0 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03441555Phase 1 · completed A Study of Venetoclax and Alvocidib in Patients With Relapsed/Refractory Acute Myeloid Leukemia · 63 trials list this drug (0 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04493099Phase 1/Phase 2 · withdrawn Alvocidib in Combination With Decitabine and Venetoclax in Patients With Relapsed or Refractory AML or as Frontline Therapy in Unfit Patients With AML · 63 trials list this drug (0 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00005074Phase 2 · completed Flavopiridol in Treating Patients With Previously Untreated or Relapsed Mantle Cell Lymphoma · 63 trials list this drug (0 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00005971Phase 2 · completed Flavopiridol in Treating Patients With Metastatic Malignant Melanoma · 63 trials list this drug (0 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00005974Phase 2 · completed Flavopiridol in Treating Patients With Recurrent, Locally Advanced, or Metastatic Soft Tissue Sarcoma · 63 trials list this drug (0 active) | — | — | Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00094978Phase 1 · terminated Depsipeptide/Flavopiridol Infusion for Cancers of the Lungs, Esophagus, Pleura, Thymus or Mediastinum · 63 trials list this drug (0 active) | — | — | Esophageal Neoplasm,Malignant Mesothelioma,Lung Non-Small Cell Carcinoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00795002Phase 2 · completed Alvocidib, Cytarabine, and Mitoxantrone in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia · 63 trials list this drug (0 active) | — | — | Secondary Acute Myeloid Leukemia,Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome,Adult Acute Megakaryoblastic Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00445341Phase 1/Phase 2 · completed Flavopiridol to Treat Relapsed Mantle Cell Lymphoma or Diffuse Large B-Cell Lymphoma · 63 trials list this drug (0 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01349972Phase 2 · completed Alvocidib, Cytarabine, and Mitoxantrone Hydrochloride or Cytarabine and Daunorubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia · 63 trials list this drug (0 active) | — | — | Secondary Acute Myeloid Leukemia,Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome,Adult Acute Myeloid Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00058240Phase 1/Phase 2 · completed Flavopiridol in Treating Patients With Previously Treated Chronic Lymphocytic Leukemia or Lymphocytic Lymphoma · 63 trials list this drug (0 active) | — | — | Chronic Lymphocytic Leukemia,Small Lymphocytic Lymphoma,Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00957905Phase 2 · completed Alvocidib and Oxaliplatin With or Without Fluorouracil and Leucovorin Calcium in Treating Patients With Relapsed or Refractory Germ Cell Tumors · 63 trials list this drug (0 active) | — | — | Ovarian Germ Cell Tumor,Malignant Extragonadal Germ Cell Tumor,Malignant Extragonadal Nongerminomatous Germ Cell Tumor+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00098371Phase 2 · terminated Flavopiridol in Treating Patients With Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia · 63 trials list this drug (0 active) | — | — | Chronic Lymphocytic Leukemia,Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00112723Phase 1/Phase 2 · terminated Flavopiridol in Treating Patients With Relapsed or Refractory Lymphoma or Multiple Myeloma · 63 trials list this drug (0 active) | — | — | Anaplastic Large Cell Lymphoma,Multiple Myeloma,Non-Hodgkin Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01076556Phase 1 · terminated Cyclophosphamide, Alvocidib, and Rituximab in Treating Patients With High Risk B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma · 63 trials list this drug (0 active) | — | — | Chronic Lymphocytic Leukemia,Prolymphocytic Leukemia,Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00407966Phase 2 · completed Alvocidib, Cytarabine, and Mitoxantrone in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia · 63 trials list this drug (0 active) | — | — | Secondary Acute Myeloid Leukemia,Adult Acute Megakaryoblastic Leukemia,Adult Acute Myeloid Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00634244Phase 2 · completed Comparing Three Different Combination Chemotherapy Regimens in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia · 63 trials list this drug (0 active) | — | — | Adult Acute Megakaryoblastic Leukemia,Adult Acute Myeloid Leukemia,Adult Acute Myeloid Leukemia with Maturation+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00019344Phase 1 · completed Flavopiridol in Treating Patients With Refractory Cancer · 63 trials list this drug (0 active) | — | — | Adult Solid Neoplasm,Lymphoma,Malignant Prostate Neoplasm+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00735930Phase 1 · completed Lenalidomide and Alvocidib in Treating Patients With Relapsed or Refractory B-cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma · 63 trials list this drug (0 active) | — | — | Chronic Lymphocytic Leukemia,Prolymphocytic Leukemia,Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00082784Phase 1 · completed Bortezomib and Flavopiridol in Treating Patients With Recurrent or Refractory Indolent B-Cell Neoplasms · 63 trials list this drug (0 active) | — | — | Multiple Myeloma,Non-Hodgkin Lymphoma,Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00331682Phase 2 · completed Docetaxel and Flavopiridol in Treating Patients With Refractory Metastatic Pancreatic Cancer · 63 trials list this drug (0 active) | — | — | Malignant Pancreatic Neoplasm,Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00991952Phase 2 · completed Irinotecan Hydrochloride With or Without Alvocidib in Treating Patients With Advanced Stomach or Gastroesophageal Junction Cancer That Cannot Be Removed By Surgery · 63 trials list this drug (0 active) | — | — | Gastric Neoplasm,Malignant Gastric Neoplasm,Gastric Diffuse Adenocarcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00083122Phase 2 · completed Cisplatin and Flavopiridol in Treating Patients With Advanced Ovarian Epithelial Cancer or Primary Peritoneal Cancer · 63 trials list this drug (0 active) | — | — | Ovarian Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00046917Phase 1 · completed Combination Chemotherapy in Treating Patients With Advanced Solid Tumors · 63 trials list this drug (0 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00112684Phase 1 · terminated Alvocidib in Treating Patients With Locally Advanced or Metastatic Solid Tumors · 63 trials list this drug (0 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00324480Phase 1 · completed Vorinostat and Alvocidib in Treating Patients With Advanced Solid Tumors · 63 trials list this drug (0 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00070239Phase 1 · terminated Alvocidib in Treating Patients With Metastatic or Unresectable Refractory Solid Tumors or Hematologic Malignancies · 63 trials list this drug (0 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm,Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00080990Phase 1 · completed Alvocidib, Oxaliplatin, Fluorouracil, and Leucovorin Calcium in Treating Patients With Advanced Solid Tumors · 63 trials list this drug (0 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00021073Phase 1 · completed Combination Chemotherapy in Treating Patients With Advanced Cancer · 63 trials list this drug (0 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00016016Phase 1/Phase 2 · completed Flavopiridol, Cytarabine, and Mitoxantrone in Treating Patients With Acute Leukemia · 63 trials list this drug (0 active) | — | — | Secondary Acute Myeloid Leukemia,Adult Acute Lymphoblastic Leukemia,Adult Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00470197Phase 1 · completed Flavopiridol, Cytarabine, and Mitoxantrone in Treating Patients With Relapsed or Refractory Acute Leukemia · 63 trials list this drug (0 active) | — | — | Malignant Neoplasm,Adult Acute Lymphoblastic Leukemia,Adult Acute Megakaryoblastic Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00012181Phase 1 · completed Flavopiridol in Treating Children With Relapsed or Refractory Solid Tumors or Lymphomas · 63 trials list this drug (0 active) | — | — | Childhood Solid Neoplasm,Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,Childhood Malignant Germ Cell Tumor+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00072436Phase 1 · completed Gemcitabine Hydrochloride and Alvocidib in Treating Patients With Solid Tumors · 63 trials list this drug (0 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00377104Phase 1 · terminated Alvocidib in Treating Patients With B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma · 63 trials list this drug (0 active) | — | — | Chronic Lymphocytic Leukemia,Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003004Phase 1 · completed Combination Chemotherapy in Treating Patients With Refractory or Recurrent Solid Tumors · 63 trials list this drug (0 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00006245Phase 2 · completed Flavopiridol and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer That Has Not Responded to Previous Paclitaxel · 63 trials list this drug (0 active) | — | — | Malignant Esophageal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00016939Phase 2 · completed Flavopiridol in Treating Patients With Unresectable or Metastatic Kidney Cancer · 63 trials list this drug (0 active) | — | — | Malignant Kidney Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00023894Phase 2 · completed Flavopiridol in Treating Patients With Recurrent or Persistent Endometrial Cancer · 63 trials list this drug (0 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00087282Phase 2 · completed Irinotecan and Flavopiridol in Treating Patients With Advanced Liver Cancer · 63 trials list this drug (0 active) | — | — | Malignant Liver Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00020189Phase 2 · completed Flavopiridol in Treating Patients With Recurrent or Metastatic Head and Neck Cancer · 63 trials list this drug (0 active) | — | — | Malignant Head and Neck Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00020332Phase 1/Phase 2 · completed Docetaxel and Flavopiridol in Treating Patients With Locally Advanced or Metastatic Breast Cancer · 63 trials list this drug (0 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00042874Phase 1 · completed Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Solid Tumors · 63 trials list this drug (0 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00047307Phase 1 · completed Flavopiridol Plus Radiation Therapy Followed By Gemcitabine Hydrochloride in Treating Patients With Locally Advanced, Unresectable Pancreatic Cancer · 63 trials list this drug (0 active) | — | — | Malignant Pancreatic Neoplasm,Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00058227Phase 1 · completed Alvocidib, Fludarabine Phosphate, and Rituximab in Treating Patients With Lymphoproliferative Disorders or Mantle Cell Lymphoma · 63 trials list this drug (0 active) | — | — | Hairy Cell Leukemia,Chronic Lymphocytic Leukemia,Small Lymphocytic Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00101231Phase 1 · terminated Flavopiridol in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Chronic Myelogenous Leukemia · 63 trials list this drug (0 active) | — | — | Adult Acute Lymphoblastic Leukemia,Adult Acute Megakaryoblastic Leukemia,Adult Acute Myeloid Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00045448Phase 1 · completed Combination Chemotherapy in Treating Patients With Advanced Solid Tumors · 63 trials list this drug (0 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00016185Phase 1 · completed Flavopiridol and Docetaxel in Treating Patients With Advanced Solid Tumors · 63 trials list this drug (0 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00278330Phase 1 · completed Flavopiridol and Vorinostat in Treating Patients With Relapsed or Refractory Acute Leukemia or Chronic Myelogenous Leukemia or Refractory Anemia · 63 trials list this drug (0 active) | — | — | Adult Acute Lymphoblastic Leukemia,Myelodysplastic Syndrome with Excess Blasts,Adult Acute Myeloid Leukemia+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00098579Phase 1 · completed Doxorubicin Hydrochloride and Alvocidib in Treating Patients With Metastatic or Recurrent Sarcoma That Cannot Be Removed By Surgery · 63 trials list this drug (0 active) | — | — | Gastrointestinal Stromal Tumor,Adult Soft Tissue Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00007917Phase 1 · completed Gemcitabine Plus Flavopiridol in Treating Patients With Advanced Solid Tumors · 63 trials list this drug (0 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00464633Phase 2 · completed Alvocidib in Patients With Previously Treated Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia Arising From Chronic Lymphocytic Leukemia (CLL) · 63 trials list this drug (0 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003256Phase 2 · completed Flavopiridol in Treating Patients With Recurrent Prostate Cancer · 63 trials list this drug (0 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003039Phase 2 · completed Flavopiridol in Treating Patients With Recurrent Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma or Mantle Cell Lymphoma · 63 trials list this drug (0 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00039455Phase 1 · terminated Trastuzumab and Flavopiridol in Treating Patients With Metastatic Breast Cancer · 63 trials list this drug (0 active) | — | — | Malignant Breast Neoplasm,Male Breast Carcinoma,HER2-Positive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00079352Phase 1 · completed Flavopiridol, Gemcitabine, and Irinotecan in Treating Patients With Unresectable or Metastatic Solid Tumors · 63 trials list this drug (0 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003620Phase 2 · completed Flavopiridol in Treating Patients With Chronic Lymphocytic Leukemia · 63 trials list this drug (0 active) | — | — | Chronic Lymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00047203Phase 2 · completed Flavopiridol in Treating Patients With Relapsed or Refractory Multiple Myeloma · 63 trials list this drug (0 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003690Phase 1 · completed Flavopiridol Plus Cisplatin or Carboplatin in Treating Patients With Advanced Solid Tumors · 63 trials list this drug (0 active) | — | — | Adult Solid Neoplasm,Malignant Breast Neoplasm,Melanoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00064285Phase 1 · completed Flavopiridol and Imatinib Mesylate in Treating Patients With Hematologic Cancer · 63 trials list this drug (0 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00006485Phase 1 · completed Flavopiridol and Irinotecan in Treating Patients With Advanced Solid Tumors · 63 trials list this drug (0 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |